does glp-1 cause breast cancer Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management GLP-1 use linked to lower
Description
Bottom line: GLP-1 injections for weight loss GLP-1 injections are changing the way people approach weight loss
However, compounded GLP-1 medications may not be FDA-approved, and the FDA has warned about adverse events in some compounded semaglutide cases
Neurochem Int 128:94105
A study conducted by Uijl E
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for the management of type 2 diabetes and obesity, yet their long-term cardiovascular effects in high-risk populations continue to be actively evaluated
used in Ozempic and Wegovy
